Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

June 7, 2023
Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared HolzMerck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

Jared Holz, Mizuho healthcare sector specialist, joins ‘Fast Money’ to discuss Merck’s lawsuit against the federal government over Medicare drug pricing.

Share This

Latest Mizuho News

Mizuho Americas and Pursuit Launch AI Nonprofit Build Corps

Mizuho Americas and Pursuit Launch AI Nonprofit Build Corps

February 11, 2026
Novo Nordisk is being more cautious on Medicare, says Mizuho’s Holz

Novo Nordisk is being more cautious on Medicare, says Mizuho’s Holz

February 4, 2026
Paypal’s network value is still huge following leadership shuffle, says Mizuho’s Dan Dolev

Paypal’s network value is still huge following leadership shuffle, says Mizuho’s Dan Dolev

February 3, 2026

Mizuho news from around the globe

back-to-top-blue